Patents by Inventor Francesca SCHIARETTI

Francesca SCHIARETTI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DRY POWDER FORMULATION COMPRISING A PHOSPHODIESTERASE INHIBITOR
    Publication number: 20150342936
    Abstract: Pharmaceutical formulations in the form of inhalable dry powder comprising particles of a phosphodiesterase-4 inhibitor as active ingredient are useful for the prevention and/or treatment of respiratory diseases, such as asthma and COPD.
    Type: Application
    Filed: August 7, 2015
    Publication date: December 3, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela COCCONI, Francesca Schiaretti, Roberto Bilzi
  • USE OF MAGNESIUM STEARATE IN DRY POWDER FORMULATIONS FOR INHALATION
    Publication number: 20150320691
    Abstract: Addition of magnesium stearate to a powder formulation for inhalation comprising carrier particles and an active ingredient bearing a group susceptible to hydrolysis is useful for inhibiting or reducing the chemical degradation of the active ingredient.
    Type: Application
    Filed: July 17, 2015
    Publication date: November 12, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela COCCONI, Massimiliano Dagli ALBERI, Andrea BUSCA, Francesca SCHIARETTI
  • Dry powder formulation comprising a phosphodiesterase inhibitor
    Patent number: 9132121
    Abstract: Pharmaceutical formulations in the form of inhalable dry powder comprising particles of a phosphodiesterase-4 inhibitor as active ingredient are useful for the prevention and/or treatment of respiratory diseases, such as asthma and COPD.
    Type: Grant
    Filed: August 2, 2011
    Date of Patent: September 15, 2015
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela Cocconi, Francesca Schiaretti, Roberto Bilzi
  • DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC FOR ADMINISTRATION BY INHALATION
    Publication number: 20150017248
    Abstract: Dry powder formulations for inhalation comprising a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of inflammatory and/or obstructive airways diseases.
    Type: Application
    Filed: July 10, 2014
    Publication date: January 15, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Irene PASQUALI, Rossella Musa, Francesca Schiaretti, Azita Askey-Sarvar
  • USE OF MAGNESIUM STEARATE IN DRY POWDER FORMULATIONS FOR INHALATION
    Publication number: 20120082727
    Abstract: Addition of magnesium stearate to a powder formulation for inhalation comprising carrier particles and an active ingredient bearing a group susceptible to hydrolysis is useful for inhibiting or reducing the chemical degradation of the active ingredient.
    Type: Application
    Filed: September 22, 2011
    Publication date: April 5, 2012
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela Cocconi, Massimiliano Dagli Alberi, Andrea Busca, Francesca Schiaretti
  • DRY POWDER FORMULATION COMPRISING A PHOSPHODIESTERASE INHIBITOR
    Publication number: 20120031403
    Abstract: Pharmaceutical formulations in the form of inhalable dry powder comprising particles of a phosphodiesterase-4 inhibitor as active ingredient are useful for the prevention and/or treatment of respiratory diseases, such as asthma and COPD.
    Type: Application
    Filed: August 2, 2011
    Publication date: February 9, 2012
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Daniela COCCONI, Francesca Schiaretti, Roberto Bilzi
  • DRY POWDER FORMULATION COMPRISING AN ANTIMUSCARINIC DRUG
    Publication number: 20110308519
    Abstract: The invention provides dry powder formulations suitable for the inhalatory administration by means of a dry powder inhaler, comprising an antimuscarinic drug as active ingredient. The invention also provides processes for the preparation of such a formulation and method for the prevention and/or treatment of a wide range of conditions including respiratory disorders by administering such a formulation.
    Type: Application
    Filed: June 22, 2011
    Publication date: December 22, 2011
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventor: Francesca SCHIARETTI